BIO-key International, Inc. (BKYI) has a negative trailing P/E of -1.1, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -87.37%.
Criteria proven by this page:
Overall SharesGrow Score: 53/100 with 2/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -3.5 | -0.03 | 0.96 | 4.98 | 3.61% |
| 2017 | -2.7 | 0.19 | 0.85 | 1.86 | 5.37% |
| 2018 | -1.3 | 0.16 | 0.83 | 2.15 | - |
| 2019 | -0.5 | -0.01 | -3.11 | 3.14 | - |
| 2020 | -2.8 | 0.04 | 1.35 | 9.64 | - |
| 2021 | -3.4 | 0.05 | 1.10 | 3.37 | - |
| 2022 | -0.4 | 0.00 | 0.89 | 0.68 | - |
| 2023 | -0.2 | 0.00 | 1.58 | 0.22 | - |
| 2024 | -1.5 | 0.02 | 1.75 | 0.95 | - |
| 2025 | -0.8 | 0.02 | 0.47 | 0.59 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-6.00 | $2.98M | $-4.19M | -140.8% |
| 2017 | $-5.15 | $6.3M | $-4.28M | -67.8% |
| 2018 | $-4.73 | $4.04M | $-6.87M | -169.8% |
| 2019 | $-148.35 | $2.27M | $-14.65M | -646.2% |
| 2020 | $-52.04 | $2.84M | $-13.59M | -479.1% |
| 2021 | $-10.56 | $5.11M | $-4.57M | -89.3% |
| 2022 | $-23.87 | $7.02M | $-10.74M | -153% |
| 2023 | $-15.21 | $7.75M | $-8.52M | -109.9% |
| 2024 | $-0.03 | $6.93M | $-4.3M | -62.1% |
| 2025 | $-0.69 | $6.1M | $-4.59M | -75.3% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-0.32 | $-0.32 – $-0.32 | $9M | $9M – $9M | 1 |
| 2027 | $0.00 | $0.00 – $0.00 | $12M | $12M – $12M | 0 |
